pharma · Chronic Lymphocytic Leukemia · Relapsing Multiple Sclerosis · TGTX
TG THERAPEUTICS
TG THERAPEUTICS, INC.
TG THERAPEUTICS clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3020 Carrington Mill Blvd, Suite 475, Morrisville, North Carolina 27560, US
- Founded
- 2011
- Employees
- 521
- Programs
- 39
- Drugs
- 23
- Patents
- 7
TG THERAPEUTICS projects
13 ClinicalTrials.gov programs sponsored by TG THERAPEUTICS.
TG THERAPEUTICS has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Acalabrutinib
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial -
Pembrolizumab
TG THERAPEUTICS, INC.
Hodgkin's Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Follicular Lymphoma
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Relapsing Remitting Multiple Sclerosis
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Follicular Lymphoma
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
multiple sclerosis
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Autoimmune Disorders
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Non-Hodgkins Lymphoma
2 trials -
Umbralisib
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
4 trials -
Umbralisib
TG THERAPEUTICS, INC.
Lymphoma
1 trial -
Umbralisib
TG THERAPEUTICS, INC.
Marginal Zone Lymphoma
1 trial -
Venetoclax
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial
Frequently asked questions
How many clinical projects does TG THERAPEUTICS have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.